Eam Investors, LLC G1 Therapeutics, Inc. Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$5.17 - $16.99 $1.16 Million - $3.8 Million	223,654 New	223,654 $2.79 Million
Q3 2019 Nov 13, 2019	SELL	$22.78 - $40.58 $769,303 - $1.37 Million	-33,771 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $541,349 - $1.05 Million	33,771 New	33,771 $1.04 Million
Q2 2018 Aug 03, 2018	SELL	$35.06 - $51.17 $3.46 Million - $5.04 Million	-98,551 Closed	0 $0
Q1 2018 May 14, 2018	BUY	$19.05 - $41.76 $1.88 Million - $4.12 Million	98,551 New	98,551 $3.65 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.